Crossmark

Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial

Crossref DOI link: https://doi.org/10.1186/s13058-018-0976-0

Published Online: 2018-06-08

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Larsson, Anna-Maria

Jansson, Sara

Bendahl, Pär-Ola

Levin Tykjaer Jörgensen, Charlotte

Loman, Niklas

Graffman, Cecilia

Lundgren, Lotta

Aaltonen, Kristina

Rydén, Lisa http://orcid.org/0000-0001-7515-3130
Funding

Funding for this research was provided by:

Crafoordska Stiftelsen (20150961; 20170702)

Fru Berta Kamprads Stiftelse (2015-44; 2017-39)

Cancerfonden (2013/533; 2016/563)

Vetenskapsrådet (2015/02516)

BioCare a strategic research area

Governmental Funding of Clinical Research within the National Health Services
License Information

Text and Data Mining valid from 2018-06-08
More Information

Article History

Received: 21 January 2018

Accepted: 2 May 2018

First Online: 8 June 2018

Ethics approval

: The study was approved by the Ethics Committee at Lund University, Lund, Sweden (LU 2010/135).

: All included patients provided written informed consent for publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below